Cytovance in Agreement with Akshaya

By • on May 2, 2020

The Journal Record website reported that Cytovance Biologics has entered into a collaboration agreement with Akshaya Bio Inc. to provide rapid access to clinical materials using Akshaya’s proprietary Chimigen Platform Technology for vaccine development for COVID-19 and hepatitis B vaccine. Oklahoma City-based Cytovance Biologics is a contract development and manufacturing organization and a subsidiary of the Shenzhen Hepalink Pharmaceutical Group Co. Ajsgata is a Canadian development stage biotechnology company.“Our Open Innovation program has a primary focus of bringing new and state-of-the-art technology into our company. This collaboration with Akshaya is a great example of our commitment to innovation,” said April Stanley, associate director of open innovation at Cytovance.

Click here to read the full article.

 

Related Posts

Related Entries

Recent Entries

Purchase viagra online and purchase it from the good to cope with dependable and trustworthy pharmacy. Don't believe of the recommendation by a mantra but instead as suggestion that is useful since that might be really a correct move to make to think about. It's not just about general ease of doing all of your buying resting before your Computer, or around no prerequisite to depart your home or stand-in point, but additionally concerning the choices you might have barely considered overall. Visit the drugstore you might have handled earlier in the event that you know the thing you need precisely. Examine the options what, why and just how if, nevertheless, you will find neither particular needs or a drugstore to go to.